Medical Management News

Showcase

Med Tech Outlook: Top Medical Ventilator Solution Providers 2021

Accurate breath analysis is key for diagnosis and assessment of pulmonary illnesses. Breath analysis is an important evaluation tool to support respiratory therapists and pulmonologists in the diagnosis and treatment of varying respiratory illnesses. Unfortunately, moisture is an impediment to successful breath analysis. Moisture in breath samples can adversely impact the accuracy of breath ...

Jun. 19, 2021

By Perma Pure LLC - a Halma Company

Thermo Fisher Scientific Announces Oncomine Clinical Research Grant Program Call for Submissions to Support Research in Immuno-oncology

Thermo Fisher Scientific today announced that submissions are now open for the Oncomine Clinical Research Grant program to support clinical research projects in oncology. This grant aims to provide funding for high-quality molecular profiling studies focusing on the impact of immune-based treatments for cancer patients. Through the Oncomine Clinical Research Grant program, Thermo Fisher will ...

Jun. 16, 2021

By Thermo Fisher Scientific, LIMS & Laboratory Software

Thermo Fisher Scientific Introduces New Quick to Clinic Solution to Help Biologic Drug Developers Accelerate Preclinical Development at BIO Digital 2021

BIO DIGITAL 2021 – New and emerging biopharma companies working on early development can now leverage a better lab to clinic drug development solution designed to accelerate the journey from DNA to drug product. The enhanced Quick to Clinic solution from Thermo Fisher Scientific may help biopharma companies reach Phase I/First-In-Human trials and file for Investigational New Drug (IND) ...

Jun. 14, 2021

By Thermo Fisher Scientific, LIMS & Laboratory Software

Kiverco invest 5k in Mid Ulster Mental Health Services

Mid Ulster Association for Counselling and Psychotherapy is relocating to a brand-new state-of-the-art building located in Coalisland, Co Tyrone. The centre due to open at its new location in August, offers free counselling services to anyone who resides or works within the Mid Ulster area. The MACP charity offers guidance on a number of issues that can affect mental health including stress, ...

Jun. 10, 2021

By Kiverco Recycling Systems Ltd.

Creative Enzymes Upgrades Multiple Diagnostic Enzyme Products for Clinical and Diagnostic Research

Creative Enzymes, the world’s leading diagnostic enzyme production company, has been committed to providing customers with various enzyme products and services for medical and research diagnosis. Relying on its professional team and the most advanced technology, as well as high-quality products and services, it has gained solid reputation. Recently, Creative Enzymes has announced multiple ...

May 25, 2021

By Creative Enzymes

Thermo Fisher Scientific and University of California, San Francisco to Open Cell Therapy cGMP Manufacturing and Collaboration Center

Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, and the University of California, San Francisco (UCSF) today announced they have formed a strategic alliance to accelerate the development and manufacturing of cell-based therapies. Under the agreement, Thermo Fisher will build and operate a 44,000-square-foot, state-of-the-art cell therapy development, manufacturing ...

May 20, 2021

By Thermo Fisher Scientific, LIMS & Laboratory Software

China International Pharmaceutical Machinery Expo (CIPM)

Puretech Process Systems Ltd’s distributor ITS Science & Medical will be representing us at the China International Pharmaceutical Machinery Exposition (CIPM) 10 -12th May 2021. James Steptoe, our Global Sales Manager, will be supporting ITS remotely on Zoom. To contact James please send him a ...

May 6, 2021

By Puretech Process Systems Limited

Silver Birches Ward, Chase Farm Hospital

Flex7 lighting connection and control products were recently installed at Chase Farm Hospital, part of Barnet Enfield and Haringey Mental Health Trust. The project is part of The Government’s pledge to eradicate dormitory accommodation from mental health facilities. Silver Birches Ward at Chase Farm Hospital was one of the sites included when the first 21 NHS Trusts to receive funding ...

Apr. 28, 2021

By Flex7 Ltd

Exosome Services at Creative Biolabs to Accelerate Lung Cancer Research

As the incidence and mortality of lung cancer rank among the highest all over the world, lung cancer diagnostics and treatment are the most researched paper topics. Research has reported that exosomes derived from lung cancer are the most promising biomarkers for early diagnosis, prognosis, and treatment of lung cancer. With years of experience in this field, Creative Biolabs provides exosome ...

Apr. 28, 2021

By Creative Biolabs

MediPines AGM100 Voted as Finalist in Medical Design Excellence Awards, MDEA 2021

We are pleased to announce that MediPines AGM100, a non-invasive pulmonary gas exchange analyzer, was selected as a finalist in the 2021 Medical Design Excellence Awards (MDEA). The MDEAs is the premier design competition in the MedTech industry organized by MD+DI and recognizes the significant achievements in medical product design and engineering that improve the quality of healthcare delivery ...

Apr. 27, 2021

By MediPines

Scivita Medical Raises Nearly RMB0.4 Billion in Series a Funding Round and Strives to Build a World-leading Platform for Innovative Products in Endoscope and Related Fields

Scivita Medical Technology Co., Ltd. ('Scivita Medical*) today announced that it has raised nearly RMB0.4 Billion in Series A funding round, which has become one of the highest financing projects in the field of endoscope in China in recent years. The investment was jointly led by GL Ventures and Lilly Asia Ventures with contribution from Matrix Partners China, Medtronic, Chengwei Capital and ...

Apr. 26, 2021

By Scivita Medical Technology Co., Ltd.

Malaria Vaccine Phase 2b Clinical Trial Results Published in Preprints with The Lancet

Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the pre-print publication of data from a Phase 2b clinical trial in children demonstrating 77 percent efficacy for a malaria vaccine candidate, R21, created by the University of Oxford that includes Novavax' Matrix-M™ adjuvant and is licensed to Serum ...

Apr. 23, 2021

By Novavax

BioStable Science & Engineering Announces CE Mark Approval for the HAART 200 Aortic Annuloplasty Device & Surpasses 1,000 Patients Treated Worldwide with the HAART Devices

BioStable Science & Engineering, Inc., (“BioStable”) announced today the company has received CE Mark approval for the HAART 200 Aortic Annuloplasty Device for use during bicuspid aortic valve repair. With CE Mark approval of both the HAART 300 and HAART 200 Aortic Annuloplasty Devices, BioStable will be able to offer surgeons within the European Union a comprehensive portfolio of ...

Apr. 21, 2021

By BioStable Science & Engineering, Inc.

CEO Eliane Schutte among Top 50 Medtech CEOs

Xeltis CEO Eliane Schutte has been included in the Healthcare Technology Report’s list of 2021 Top 50 Healthcare Technology CEOs, one of only seven women featuring on the list. The Report’s list recognizes the most accomplished executives in the healthcare technology, whose leadership has been critical in developing industry leading medical devices, next generation software ...

Apr. 19, 2021

By XELTIS BV

Thermo Fisher Scientific to Acquire PPD, Inc., a Leading Clinical Research Organization

Establishes Thermo Fisher as a global leader in the attractive and high growth clinical research services industry Adds highly complementary services for the company's fastest growing end market Offers both meaningful cost and revenue synergies which will further accelerate growth Expected to be immediately and significantly accretive to Adjusted Earnings Per Share (EPS)¹ after close ...

Apr. 15, 2021

By Thermo Fisher Scientific, LIMS & Laboratory Software

Smiths Detection announces University of Maryland, Baltimore County successfully deploys BioFlash for airborne detection of SARS-CoV-2

Smiths Detection, a global leader in threat detection and security screening technologies, today announces that its BioFlash Biological Identifier has been successfully used by the University of Maryland, Baltimore County (UMBC) to identify airborne SARS-CoV-2 inside their campus in real-time at the point of testing. As part of their mitigation strategy for COVID-19, UMBC’s Environmental ...

Apr. 13, 2021

By Smiths Detection Inc.

AACR Presentation #1731 : EXS21546, a non-CNS penetrant A2AR-selective antagonist for anti-cancer immunotherapy

Our AACR Presentation #1731 is now available. Follow this link to the AACR web site and this link to see our Poster: Abstract Elevated levels of adenosine found in the tumor microenvironment have been highlighted as a potential mechanism contributing to the restricted efficacy of immune checkpoint inhibitors. While the advent of these inhibitors has brought significant benefit to patients with ...

Apr. 12, 2021

By Exscientia

Exscientia Announces First AI-Designed Immuno-Oncology Drug to Enter Clinical Trials

Company’s technologies and drug-hunting expertise now responsible for world’s first and second AI-designed drugs to enter Phase I testing Exscientia, a leading artificial intelligence (AI) driven pharmatech company, today announced the first AI-designed molecule for immuno-oncology to enter human clinical trials. The A2a receptor antagonist, which is in development for adult patients ...

Apr. 9, 2021

By Exscientia

Data from Eli Lilly’s COV-BARRIER trial shows baricitinib reduced deaths in hospitalised COVID-19 patients by 38%

The latest data published in Eli Lilly’s Phase 3 randomised, double-blind, placebo-controlled study (COV-BARRIER) shows the largest clinical effect reported to date for a reduction in mortality in the COVID-19 patient population. ‍ Early in the pandemic, BenevolentAI researchers identified Baricitinib as a potential treatment for COVID-19 and published the hypothesis in The Lancet ...

Apr. 8, 2021

By Benevolent

Evaxion Biotech Announces Q4 and Full-Year 2020 Financial Results and Provides Business Update

Successfully completed initial public offering on U.S. Nasdaq in February 2021, raising gross proceeds of $30 million Clinical development on track with dosing of first patient in Phase 1/2a melanoma trial of cancer vaccine EVX-02 Cash reserves of $5.8 million at December 31, 2020 plus funds from IPO provide funding for at least 12 months from the date of completion of the IPO COPENHAGEN, ...

Apr. 6, 2021

By Evaxion Biotech A/S